% 71.9% Total Revenue 100.0% 100.0% 100.0% THB (mn) 1Q 2019/20 (Restated) 4Q 2019/20 1Q 2020/21 QoQ (%) YoY (%) Operating revenue 690 612 512 -16.4% -25.9% Cost of sales 429 465 453 -2.6% 5.7% Gross profit

(Unit : THB million) 2015 2016 9 months of 2017 Gross written premium 101.26 163.34 128.44 Net written premium 91.21 156.86 81.01 Total revenues 121.22 126.80 110.11 Underwriting and Operating expenses

วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC002/2018 February 28, 2018 Subject : The company’s operating result of the year 2017. To : The president, The Stock Exchange of

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the second quarter of 2019 at the end of 30th June 2019 as follows

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 30th September 2018 as

Company”) would like to summarize its Q3/2019 operating performance for the period ending 30 September 2019 as follows: For the three-month, the Company and its subsidiaries’ posted a net profit of Baht

Public Company Limited (“the Company”) would like to submit the management discussion and analysis of the operating results for the nine months of 2020 ended September 30, 2020 as follows: Overall Group

18.92 9.93 Gross profit 7.57 -0.26 1.82 Operating expenses 10.29 6.20 4.93 EBIT -2.71 -6.45 -3.11 Total Other revenue 1.12 0.22 0.04 Finance cost 1.11 0.96 0.22 Income tax 0.00 0.00 0.00 Net profit(loss

expenses to total operating income is at 42.6%, which is increased when compared to the second quarter of 2016 was at 35.0%. For the six-month period of 2017, they had other operating expenses amounted of

expansion. The ratio of operating expenses to total operating income was at 41.4%, which was increased when compared to the third quarter of 2016 was at 38.5%. For the nine-month period of 2017, the company